Iams Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
Iams Wealth Management's FBT Position: Q3 2026 in Review
Iams Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 4,850 shares — an estimated $1.2M sold.
Iams Wealth Management first reported a position in FBT in Q3 2024 and held it in 8 quarters. The position peaked at $1.2M in Q2 2026. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.
- Iams Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
- Iams Wealth Management sold 4,850 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $1.2M.
- Iams Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and held it in 8 quarters.
- Iams Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.2M in Q2 2026.
- 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.
Based on Iams Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.